Ventricular Arrhythmia Clinical Trial
Official title:
Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients
The purpose of this 2-group randomized clinical trial is to: 1) examine the feasibility and acceptability of a 3-month positive-emotion focused therapy (Quality of Life Therapy) modified specifically for patients with implantable cardioverter defibrillator (ICD); and 2) obtain estimates of effect size for QOLT compared to Heart Healthy Education on the changes in arrhythmia frequency and biomarkers of autonomic function, as well as changes in emotion, mood, and well-being across time (baseline, 3 & 9-months). It is hypothesized that the QOLT will promote improvements in autonomic function, reduced arrhythmia frequency, and improved psychological well-being.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02104583 -
Evaluating Ventricular Arrhythmia in Subjects With Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy-Defibrillator
|
Phase 2 | |
Active, not recruiting |
NCT01281241 -
Study on Mechanical and Electrical Alternans
|
N/A | |
Completed |
NCT00993382 -
Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death
|
Phase 2 | |
Completed |
NCT00000504 -
Cardiac Arrhythmia Pilot Study (CAPS)
|
Phase 2 | |
Recruiting |
NCT06048731 -
Enlighten Study: The EV-ICD Post Approval Registry
|
||
Terminated |
NCT02114528 -
Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
|
Phase 4 | |
Completed |
NCT05099289 -
Parasternal Access for ShockS and Pacing With an acUtely Placed Less-invasive Lead for EV-ICD (PASS PULL EV-ICD) Study
|
N/A | |
Completed |
NCT05352776 -
Sensing and Defibrillation With a Commercially Available ICD Coupled With a Parasternal Extravascular Lead (SECURE EV) Study
|
N/A | |
Recruiting |
NCT01999140 -
Implantable Cardioverter Defibrillator (ICD Registry)
|
||
Completed |
NCT00064558 -
Genetic Determinants of Sudden Cardiac Death
|
||
Completed |
NCT00000518 -
Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
|
Phase 3 | |
Completed |
NCT00102180 -
Drug-Induced Sudden Death & Ventricular Arrhythmia
|
||
Completed |
NCT00006501 -
Prognostic Significance of T Wave Alternans
|
N/A | |
Completed |
NCT01804439 -
Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes
|
N/A | |
Completed |
NCT02881255 -
Avoid Transvenous Leads in Appropriate Subjects
|
N/A | |
Completed |
NCT00000540 -
Coronary Artery Bypass Graft (CABG) Patch Trial
|
Phase 3 | |
Completed |
NCT00005235 -
Heart Rate Variability and Sudden Cardiac Death
|
N/A | |
Completed |
NCT00005197 -
Predictors of Perioperative Cardiac Morbidity
|
N/A | |
Enrolling by invitation |
NCT04520347 -
IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry
|
||
Completed |
NCT00000526 -
Cardiac Arrhythmia Suppression Trial (CAST)
|
Phase 3 |